𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Asymptomatic pulmonary cryptococcosis in a patient with Crohn's disease on infliximab: Case report

✍ Scribed by Fumihito Hirai; Toshiyuki Matsui; Yukiko Ishibashi; Daijirou Higashi; Kitarou Futami; Seiji Haraoka; Akinori Iwashita


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
103 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Splenic tuberculosis in a patient with C
✍ Maria Cappello; Claudia Randazzo; Giulia Rizzuto; Celestino Bonura; Gaetano Di V πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 255 KB

FIGURE 1. MRI of the spleen. a: T1-weighted image on dynamic contrast-enhancement (axial). b: T1-weighted image on dynamic contrast-enhancement (coronal).

Salmonella septic arthritis in a patient
✍ Jean Y. Rim; Allan R. Tenorio πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 1 views

The use of tumor necrosis factor a (TNFa) inhibitors such as infliximab, etanercept, and adalimumab for various autoimmune diseases, including Crohn's disease (CD) and ulcerative colitis (UC), has increased in the past few years. While associated with symptomatic relief in many patients, the use of

Severe Legionella pneumophila pneumonia
✍ Florian Beigel; Matthias JΓΌrgens; Levent Filik; Lutz Bader; Christian LΓΌck; Burk πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 225 KB

## Background: Immunosuppressive therapy with anti-tnf-alpha antibodies is effective in patients with inflammatory bowel disease (ibd). however, there is an increased risk for infections associated with this therapy. ## Methods: Here, we report the case of a 58-year-old patient with crohn's disea